FONAR CORP

FONAR CORP (ticker FONR) brings together MRI innovation and patient-centered diagnostic services within the Electromedical & Electrotherapeutic Apparatus SIC 3841 landscape, supplying high-field superconducting scanners, mobile imaging units, and related repair/maintenance programs to hospitals, imaging centers, and specialty clinics focused on advanced neuro, orthopedic, and cancer care pathways; the company balances longstanding IP around its patent-protected O-scan and SynchroPatent platforms with a managed-services approach aimed at small hospital systems and outpatient networks seeking affordable, in-house imaging autonomy. Targeted customers rely on FONAR’s turn-key support for compliance with FDA, Medicare, and state radiology licensure rules, even as shifts in reimbursement policy, capital budgeting cycles, and supply-chain dependencies pose material risks to new scanner deployments and service contracts; the Nov 2025 Form 8-K highlights leadership adjustments and ongoing regulatory monitoring of MR safety standards. CIK 355019 keeps investors apprised of evolving disclosures, so view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025